NCT07210632 Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG) Status RECRUITING Phase EARLY_PHASE1
NCT07179328 Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy Status RECRUITING Phase PHASE1
NCT05538130 A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT05503797 A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations Status RECRUITING Phase PHASE2